Literature DB >> 2406668

Polyhydramnios with maternal lithium treatment.

S Krause1, F Ebbesen, A P Lange.   

Abstract

Severe polyhydramnios, probably due to fetal lithium toxicity, is described. The mother had been treated with lithium because of manic-depressive psychosis. The plasma lithium level during the pregnancy was in or below the therapeutic range. From the 26th week of gestation, polyhydramnios developed. In the 35th week, 11.5 L of amniotic fluid was removed over a period of 12 hours by transabdominal amniocentesis. A cesarean delivery was performed in the 39th week of gestation because of fetal distress. The infant presented with the following symptoms, which in previous reports have been associated with lithium toxicity: asphyxia, apnea, cardiac decompensation, respiratory distress, hypoglycemia, thrombocytopenia, diabetes insipidus, hypotonia, and convulsions. The polyhydramnios was probably caused by fetal diabetes insipidus, possibly combined with cardiac decompensation. Lithium can be toxic to the infant and the fetus even though the mother is not affected and has a normal or low plasma lithium level. Polyhydramnios may be a sign of fetal lithium toxicity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2406668

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

Review 1.  Drug-induced congenital defects: strategies to reduce the incidence.

Authors:  M De Santis; B Carducci; A F Cavaliere; L De Santis; G Straface; A Caruso
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Therapeutic drug monitoring in pregnancy: rationale and current status.

Authors:  C Knott; F Reynolds
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 3.  Lithium Use and Non-use for Pregnant and Postpartum Women with Bipolar Disorder.

Authors:  Alison Hermann; Alyson Gorun; Abigail Benudis
Journal:  Curr Psychiatry Rep       Date:  2019-11-07       Impact factor: 5.285

Review 4.  Treating recurrent affective disorders during and after pregnancy. What can be taken safely?

Authors:  M Schou
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

5.  Obstetric outcomes regarding the use of lithium in pregnant women with bipolar disorders: a prospective cohort study.

Authors:  Maria Sagué-Vilavella; Eva Solé; Justo Pinzón-Espinosa; Ana Sandra-Hernández; Ester Roda; Eduard Vieta; Alba Roca
Journal:  Arch Womens Ment Health       Date:  2022-05-06       Impact factor: 4.405

6.  Lithium During Pregnancy : Drug Effects and Their Therapeutic Implications.

Authors:  K A Yonkers; B B Little; D March
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

Review 7.  Lithium during pregnancy and after delivery: a review.

Authors:  Eline M P Poels; Hilmar H Bijma; Megan Galbally; Veerle Bergink
Journal:  Int J Bipolar Disord       Date:  2018-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.